BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12627038)

  • 1. Clinical and personal relationships between oral contraceptive and hormone replacement therapy use among US women physicians.
    Frank E; Elon L
    Menopause; 2003; 10(2):133-41. PubMed ID: 12627038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personal use of postmenopausal hormone replacement therapy by women physicians in the United States.
    McNagny SE; Wenger NK; Frank E
    Ann Intern Med; 1997 Dec; 127(12):1093-6. PubMed ID: 9412312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why do women doctors in the UK take hormone replacement therapy?
    Isaacs AJ; Britton AR; McPherson K
    J Epidemiol Community Health; 1997 Aug; 51(4):373-7. PubMed ID: 9328541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women.
    Norman SA; Berlin JA; Weber AL; Strom BL; Daling JR; Weiss LK; Marchbanks PA; Bernstein L; Voigt LF; McDonald JA; Ursin G; Liff JM; Burkman RT; Malone KE; Simon MS; Folger SG; Deapen D; Wingo PA; Spirtas R
    Cancer Causes Control; 2003 Dec; 14(10):933-43. PubMed ID: 14750532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use.
    den Tonkelaar I; Oddens BJ
    Contraception; 1999 Jun; 59(6):357-62. PubMed ID: 10518229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personal use of HRT by postmenopausal women doctors and doctors' wives in the north of Italy.
    Biglia N; Cozzarella M; Ponzone R; Marenco D; Maggiorotto F; Fuso L; Sismondi P
    Gynecol Endocrinol; 2004 Mar; 18(3):165-74. PubMed ID: 15255286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
    Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
    Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The North American Menopause Society 1998 menopause survey: Part II. Counseling about hormone replacement therapy: association with socioeconomic status and access to medical care.
    Ettinger B; Woods NF; Barrett-Connor E; Pressman A
    Menopause; 2000; 7(3):143-8. PubMed ID: 10810958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy and previous use of oral contraceptives among Swedish women.
    Hammar M; Brynhildsen J; Dabrosin L; Frisk J; Lindgren R; Nedstrand E; Wyon Y
    Maturitas; 1996 Nov; 25(3):193-9. PubMed ID: 8981336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of breast cancer associated with oral contraception and hormone replacement therapy.
    Speroff L
    Womens Health Issues; 1992; 2(2):63-72; discussion 73-4. PubMed ID: 1535527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Estrogen and natural products in the treatment of postmenopausal complaints. Oral contraceptives prepare the way for hormonal substitution].
    Hammar M; Frisk J; Brynhildsen J; Dabrosin L; Lindgren R; Nedstrand E; Wyon Y
    Lakartidningen; 1997 Mar; 94(12):1084-8. PubMed ID: 9121242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study.
    Lund E; Bakken K; Dumeaux V; Andersen V; Kumle M
    Int J Cancer; 2007 Aug; 121(3):645-8. PubMed ID: 17372914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians.
    Krauss GL; Brandt J; Campbell M; Plate C; Summerfield M
    Neurology; 1996 Jun; 46(6):1534-9. PubMed ID: 8649543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HRT management: the American experience.
    Carr BR
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S17-20. PubMed ID: 8732468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy).
    Tzingounis V; Cardamakis E; Ginopoulos P; Argiropoulos G
    Anticancer Res; 1996; 16(6C):3997-4000. PubMed ID: 9042326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UK women doctors' use of hormone replacement therapy: 10-year follow up.
    Isaacs AJ; Drew SV; McPherson K
    Climacteric; 2005 Jun; 8(2):154-61. PubMed ID: 16096171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes toward hormone replacement therapy in the new millennium: university physicians' and patients' perspectives.
    Ismail HM; Aleveritis E; Guha B; Olive K; Sloan S
    J Investig Med; 2005 Sep; 53(6):305-11. PubMed ID: 16207467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise counseling and personal exercise habits of US women physicians.
    Frank E; Bhat Schelbert K; Elon L
    J Am Med Womens Assoc (1972); 2003; 58(3):178-84. PubMed ID: 12948110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement and menopausal symptoms following hysterectomy.
    Langenberg P; Kjerulff KH; Stolley PD
    Am J Epidemiol; 1997 Nov; 146(10):870-80. PubMed ID: 9384207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician specialty is significantly associated with hormone replacement therapy use.
    Levy BT; Ritchie JM; Smith E; Gray T; Zhang W
    Obstet Gynecol; 2003 Jan; 101(1):114-22. PubMed ID: 12517655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.